School of Clinical Science, University of Bristol, Learning and Research Centre, Southmead Hospital, Bristol, UK.
MRC Centre for Regenerative Medicine, SCRM Building, The University of Edinburgh, Edinburgh Bioquarter 5 Little France Drive, Edinburgh, UK.
Sci Rep. 2019 Mar 13;9(1):4370. doi: 10.1038/s41598-019-39552-0.
For many diseases with a foetal origin, the cause for the disease initiation remains unknown. Common childhood acute leukaemia is thought to be caused by two hits, the first in utero and the second in childhood in response to infection. The mechanism for the initial DNA damaging event are unknown. Here we have used in vitro, ex vivo and in vivo models to show that a placental barrier will respond to agents that are suspected of initiating childhood leukaemia by releasing factors that cause DNA damage in cord blood and bone marrow cells, including stem cells. We show that DNA damage caused by in utero exposure can reappear postnatally after an immune challenge. Furthermore, both foetal and postnatal DNA damage are prevented by prenatal exposure of the placenta to a mitochondrially-targeted antioxidant. We conclude that the placenta might contribute to the first hit towards leukaemia initiation by bystander-like signalling to foetal haematopoietic cells.
对于许多起源于胎儿的疾病,其发病原因仍不清楚。人们认为,常见的儿童急性白血病是由两次打击引起的,第一次是在子宫内,第二次是在儿童时期,以应对感染。最初的 DNA 损伤事件的机制尚不清楚。在这里,我们使用体外、离体和体内模型表明,胎盘屏障会对疑似引发儿童白血病的药物产生反应,释放导致脐带血和骨髓细胞(包括干细胞)DNA 损伤的因子。我们表明,宫内暴露引起的 DNA 损伤在出生后免疫挑战后会再次出现。此外,胎儿和出生后 DNA 损伤都可以通过胎盘在产前暴露于靶向线粒体的抗氧化剂来预防。我们得出结论,胎盘可能通过旁分泌样信号向胎儿造血细胞传递信号,从而导致白血病的首次打击。